Clinical Features



Latest Features

Upset Girl, depressed

Novel Neuroimmunologic Treatments for Depression

Depression is a major contributor to the overall global burden of disease, with more than 300 million individuals suffering from depression.1 Yet, the limited scope of therapeutics for the condition has left patients with few treatment options and low rates of remission. This may change as progress is made on the pathophysiology of depression. Indeed,…

Improving Detection of Delirium in the Acute Setting

Delirium is highly prevalent in critical care, especially among elderly patients and individuals with dementia. Although rates vary widely across studies, findings suggest delirium affects more than 15% of hospitalized patients. For additional discussion regarding this topic, Neurology Advisor interviewed Leopoldo Pozuelo, MD, MBA, FACP, FACLP, clinical vice chair of psychiatry and psychology at the Cleveland Clinic in Ohio.
doctor holding nasal spray

Ketamine Changes Course of Major Depressive Disorder Treatment

Currently, there is an unmet need for the development of rapid-acting antidepressants aimed at treatment-resistant patients with either major depressive disorder (MDD) or bipolar disorder. A review of existing treatment options, as well as future possibilities, was published in Psychiatry and Clinical Neurosciences.1 Approximately 320 million people worldwide are affected by MDD, with a noted…